Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELESTE: Insomnia Therapies for Peri- and Post-menopausal People
NCT07136415Phase 4Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2026
- Primary completion
- Feb 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trazodone hydrochloride prolonged-release tablets, daridorexant in Insomnia, sponsored by Brigham and Women's Hospital. Started Feb 2026; status: recruiting.
02
Drugs
trazodone hydrochloride prolonged-release tabletsdaridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07136415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07136415.